F. Hoffmann-La Roche Ltd’s Valuable 500 Commitment:
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies. We believe that personalised approaches achieve the best outcomes for our patients. The same is true for our employees. That’s why we are taking an individual approach to diversity & inclusion because it is personal to each individual.
Understanding disability is key to providing an inclusive and personalised experience. It allows us to provide an accessible, innovative, and empowering service for our patients, beyond our medicines and diagnostics. The commitment to our employees and the patients we serve is a key part of our overall D&| strategy.
Globally, we are committed to the following and invite our affiliates around the globe to join in making appropriate pledges based on their culture and their business:
- Coinciding with the 125th anniversary of the company, Roche pledges to evolve the corporate brand to be more human-centric and approachable, ensuring that it is accessible, especially in digital communications, to people with disabilities, and people with changes in vision due to ageing or illnesses.
- Roche commits to becoming fully digitally accessible. Digital accessibility is ensuring that information can be reached, used and understood by everyone, making sure all of our stakeholders, including our patients, can access and interact with our content.
- Working toward our ambition of a global workforce which truly represents the societies in which we live, we commit to ensuring our attraction, recruitment, retention, and development practices are accessible and inclusive, including those with disabilities and long term health conditions.
